Niederman TM - Search Results

1

Ratner L, Niederman TM. Ratner L, et al. Among authors: niederman tm. Curr Top Microbiol Immunol. 1995;193:169-208. doi: 10.1007/978-3-642-78929-8_10. Curr Top Microbiol Immunol. 1995. PMID: 7648875 Review. No abstract available.

2

Human immunodeficiency virus type 1 Nef protein inhibits NF-kappa B induction in human T cells.

Niederman TM, Garcia JV, Hastings WR, Luria S, Ratner L. Niederman TM, et al. J Virol. 1992 Oct;66(10):6213-9. doi: 10.1128/JVI.66.10.6213-6219.1992. J Virol. 1992. PMID: 1527859 Free PMC article.

3

Functional analysis of HIV1 and SIV Nef proteins.

Niederman TM, Ratner L. Niederman TM, et al. Res Virol. 1992 Jan-Feb;143(1):43-6. doi: 10.1016/s0923-2516(06)80077-4. Res Virol. 1992. PMID: 1565854 Review. No abstract available.

4

Myristoylation-enhanced binding of the HIV-1 Nef protein to T cell skeletal matrix.

Niederman TM, Hastings WR, Ratner L. Niederman TM, et al. Virology. 1993 Nov;197(1):420-5. doi: 10.1006/viro.1993.1605. Virology. 1993. PMID: 8212577

5

HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells.

Niederman TM, Hastings WR, Luria S, Bandres JC, Ratner L. Niederman TM, et al. Virology. 1993 May;194(1):338-44. doi: 10.1006/viro.1993.1264. Virology. 1993. PMID: 8480425

6

Simian immunodeficiency virus negative factor suppresses the level of viral mRNA in COS cells.

Niederman TM, Hu W, Ratner L. Niederman TM, et al. J Virol. 1991 Jul;65(7):3538-46. doi: 10.1128/JVI.65.7.3538-3546.1991. J Virol. 1991. PMID: 2041081 Free PMC article.

7

Human immunodeficiency virus type 1 negative factor is a transcriptional silencer.

Niederman TM, Thielan BJ, Ratner L. Niederman TM, et al. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1128-32. doi: 10.1073/pnas.86.4.1128. Proc Natl Acad Sci U S A. 1989. PMID: 2784001 Free PMC article.

8

A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor.

Snitkovsky S, Niederman TM, Carter BS, Mulligan RC, Young JA. Snitkovsky S, et al. Among authors: niederman tm. J Virol. 2000 Oct;74(20):9540-5. doi: 10.1128/jvi.74.20.9540-9545.2000. J Virol. 2000. PMID: 11000224 Free PMC article.

9

Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein.

Snitkovsky S, Niederman TM, Mulligan RC, Young JA. Snitkovsky S, et al. Among authors: niederman tm. J Virol. 2001 Feb;75(3):1571-5. doi: 10.1128/JVI.75.3.1571-1575.2001. J Virol. 2001. PMID: 11152532 Free PMC article.

10

Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors.

Niederman TM, Ghogawala Z, Carter BS, Tompkins HS, Russell MM, Mulligan RC. Niederman TM, et al. Proc Natl Acad Sci U S A. 2002 May 14;99(10):7009-14. doi: 10.1073/pnas.092562399. Epub 2002 May 7. Proc Natl Acad Sci U S A. 2002. PMID: 11997459 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page